| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.43 | 0.01 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.02 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.077 | 0.02 |